Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 1/2014

01-03-2014

Pancreatic Pathology in Type 1 Diabetes Mellitus

Authors: Sarah J. Richardson, Noel G. Morgan, Alan K. Foulis

Published in: Endocrine Pathology | Issue 1/2014

Login to get access

Abstract

Type 1 diabetes is a multifactorial disease resulting from a complex interplay between host genetics, the immune system and the environment, that culminates in the destruction of insulin-producing beta cells. The incidence of type 1 diabetes is increasing at an alarming rate, especially in children under the age of 5 (Gepts in Diabetes 14(10):619-613, 1965; Foulis et al. in Lancet 29(5):267-274, 1986; Gamble, Taylor and Cumming in British Medical Journal 4(5887):260-262 1973). Genetic predisposition, although clearly important, cannot explain this rise, and so, it has been proposed that changes in the ‘environment’ and/or changes in ‘how we respond to our environment’ must contribute to this rising incidence. In order to gain an improved understanding of the factors influencing the disease process, it is important, firstly, to focus on the organ at the centre of the illness—the pancreas. This review summarises our knowledge of the pathology of the endocrine pancreas in human type 1 diabetes and, in particular, explores the progression of this understanding over the past 25 years.
Literature
1.
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14 (10):619–633PubMed
2.
Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29 (5):267–274PubMedCrossRef
3.
4.
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. The New England journal of medicine 300 (21):1173–1179PubMedCrossRef
5.
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2 (7892):1279–1283PubMedCrossRef
6.
MacCuish AC, Irvine WJ, Barnes EW, Duncan LJ (1974) Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 2 (7896):1529–1531PubMedCrossRef
7.
MacCuish AC, Jordan J, Campbell CJ, Duncan LJ, Irvine WJ (1974) Cell-mediated immunity to human pancreas in diabetes mellitus. Diabetes 23 (8):693–697PubMed
8.
Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26 (6):456–461PubMedCrossRef
9.
Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. The New England journal of medicine 313 (6):353–360PubMedCrossRef
10.
Foulis AK, Farquharson MA, Hardman R (1987) Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30 (5):333–343PubMedCrossRef
11.
Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65 (1):128–139PubMedCentralPubMed
12.
Foulis AK, Farquharson MA, Meager A (1987) Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 2 (8573):1423–1427PubMedCrossRef
13.
Foulis AK (1987) C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol 152 (3):141–148PubMedCrossRef
14.
15.
Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155 (2):173–181PubMedCentralPubMedCrossRef
16.
Carrero JA, Calderon B, Towfic F, Artyomov MN, Unanue ER (2013) Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS One 8 (3):e59701.PubMedCentralPubMedCrossRef
17.
Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyoty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, Rowe PA, Tracy S, In’t Veld PA (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56 (11):2541–2543.PubMedCrossRef
18.
Silveira PA, Grey ST (2006) B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends in endocrinology and metabolism: TEM 17 (4):128–135.PubMedCrossRef
19.
Leete P, Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2013) Identification of two distinct patterns of immune cell infiltration in the insulitic lesions in human type 1 diabetes. Diabetologia 56 (Suppl1):S63
20.
Dotta F, Censini S, van Halteren AG, Marselli L, Masini M, Dionisi S, Mosca F, Boggi U, Muda AO, Prato SD, Elliott JF, Covacci A, Rappuoli R, Roep BO, Marchetti P (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proceedings of the National Academy of Sciences of the United States of America 104 (12):5115–5120PubMedCentralPubMedCrossRef
21.
Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine 209 (1):51–60.PubMedCentralPubMedCrossRef
22.
Sarkar SA, Lee CE, Victorino F, Nguyen TT, Walters JA, Burrack A, Eberlein J, Hildemann SK, Homann D (2012) Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 61 (2):436–446.PubMedCentralPubMedCrossRef
23.
Roep BO, Kleijwegt FS, van Halteren AG, Bonato V, Boggi U, Vendrame F, Marchetti P, Dotta F (2010) Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 159:338–343PubMedCentralPubMedCrossRef
24.
Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, Kikkawa Y, Sekiguchi K, Hukkanen M, Konttinen YT, Otonkoski T (2008) Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia 51 (7):1181–1191.PubMedCrossRef
25.
Irving-Rodgers HF, Ziolkowski AF, Parish CR, Sado Y, Ninomiya Y, Simeonovic CJ, Rodgers RJ (2008) Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia 51 (9):1680–1688.PubMedCentralPubMedCrossRef
26.
Korpos E, Kadri N, Kappelhoff R, Wegner J, Overall CM, Weber E, Holmberg D, Cardell S, Sorokin L (2013) The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes 62 (2):531–542.PubMedCentralPubMedCrossRef
27.
Craig ME, Nair S, Stein H, Rawlinson WD (2013) Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes 14 (3):149–158.PubMed
28.
Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ (Clinical research ed 342:d35.)
29.
Gladisch R, Hofmann W, Waldherr R (1976) [Myocarditis and insulitis following coxsackie virus infection]. Z Kardiol 65 (10):837–849PubMed
30.
Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T (2002) Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45 (5):693–702PubMedCrossRef
31.
Elshebani A, Olsson A, Westman J, Tuvemo T, Korsgren O, Frisk G (2007) Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 124 (1–2):193–203PubMedCrossRef
32.
Paananen A, Ylipaasto P, Rieder E, Hovi T, Galama J, Roivainen M (2003) Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol 69 (4):529–537PubMedCrossRef
33.
Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, Shimura H, Takizawa S, Takahashi M, Akiyama D, Arai-Yamashita S, Furuya F, Kawaguchi A, Kaneshige M, Katoh R, Endo T, Kobayashi T (2009) Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 58 (10):2285–2291.PubMedCentralPubMedCrossRef
34.
Foulis AK, McGill M, Farquharson MA, Hilton DA (1997) A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 40 (1):53–61PubMedCrossRef
35.
Hilton DA, Variend S, Pringle JH (1993) Demonstration of Coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J Pathol 170 (1):45–51.PubMedCrossRef
36.
Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R (1990) A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33 (5):290–298PubMedCrossRef
37.
Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, Roivainen M (2004) Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47 (2):225–239PubMedCrossRef
38.
Werner S, Klump WM, Schonke H, Hofschneider PH, Kandolf R (1988) Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA 7 (5):307–316PubMedCrossRef
39.
Foulis AK, Francis ND, Farquharson MA, Boylston A (1988) Massive synchronous B-cell necrosis causing type 1 (insulin-dependent) diabetes—a unique histopathological case report. Diabetologia 31 (1):46–50PubMed
40.
Sayama K, Imagawa A, Okita K, Uno S, Moriwaki M, Kozawa J, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I (2005) Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment. Diabetologia 48 (8):1560–1564PubMedCrossRef
41.
Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK (2013) Viruses in the Human Pancreas. In: Taylor KW, Hyoty H, Toniolo A, Zuckerman AJ (eds) Diabetes and Viruses. Springer, New York pp 167–176.CrossRef
42.
Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Annals of medicine 32 (8):539–543PubMedCrossRef
43.
Oikarinen S, Martiskainen M, Tauriainen S, Huhtala H, Ilonen J, Veijola R, Simell O, Knip M, Hyoty H (2011) Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60 (1):276–279.PubMedCentralPubMedCrossRef
44.
Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Hankaniemi MM, Huhtala H, Ruokoranta T, Lecouturier V, Andre P, Harju R, Virtanen SM, Lehtonen J, Almond JW, Simell T, Simell O, Ilonen J, Veijola R, Knip M, Hyoty H (2013) Coxsackievirus B1 Is Associated With Induction of beta-Cell Autoimmunity That Portends Type 1 Diabetes. Diabetes 63(2):446–55. doi:10.​2337/​db13-0619
45.
Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39 (6):741–748PubMedCrossRef
46.
Chia AY, Chia JK (2009) Intestinal intussusception in adults due to acute enterovirus infection. Journal of clinical pathology 62 (11):1026–1028PubMedCrossRef
47.
Chia JK, Chia AY (2008) Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. Journal of clinical pathology 61 (1):43–48.PubMedCrossRef
48.
Chia JK, Chia AY (2010) Acute gastritis associated with enterovirus infection. Arch Pathol Lab Med 134 (1):16–17PubMed
49.
Hammerstad SS, Tauriainen S, Hyoty H, Paulsen T, Norheim I, Dahl-Jorgensen K (2013) Detection of enterovirus in the thyroid tissue of patients with graves’ disease. J Med Virol 85 (3):512–518.PubMedCrossRef
50.
Li Y, Bourlet T, Andreoletti L, Mosnier JF, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H (2000) Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation 101 (3):231–234PubMedCrossRef
51.
Li Y, Pan Z, Ji Y, Peng T, Archard LC, Zhang H (2002) Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease. European heart journal 23 (7):567–573PubMedCrossRef
52.
Chia J, Chia A, Voeller M, Lee T, Chang R (2010) Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. Journal of clinical pathology 63 (2):165–168.PubMedCrossRef
53.
Oikarinen M, Tauriainen S, Penttila P, Keim J, Rantala I, Honkanen T, Hyoty H (2010) Evaluation of immunohistochemistry and in situ hybridization methods for the detection of enteroviruses using infected cell culture samples. J Clin Virol 47 (3):224–228.PubMedCrossRef
54.
Richardson SJ, Willcox A, Hilton DA, Tauriainen S, Hyoty H, Bone AJ, Foulis AK, Morgan NG (2010) Use of antisera directed against dsRNA to detect viral infections in formalin-fixed paraffin-embedded tissue. J Clin Virol 49 (3):180–185.PubMedCrossRef
55.
Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52 (6):1143–1151PubMedCrossRef
56.
Campbell-Thompson M, Wasserfall C, Kaddis J, Albanese-O’Neill A, Staeva T, Nierras C, Moraski J, Rowe P, Gianani R, Eisenbarth G, Crawford J, Schatz D, Pugliese A, Atkinson M (2012) Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 28(7):608–617.PubMedCentralPubMedCrossRef
57.
Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56 (1):185–193.PubMedCrossRef
58.
Hansson SF, Korsgren S, Ponten F, Korsgren O (2013) Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol 229 (5):719–728.PubMedCrossRef
59.
Richardson SJ, Leete P, Dhayal S, Russell MA, Oikarinen M, Laiho JE, Svedin E, Lind K, Rosenling T, Chapman N, Bone AJ, nPOD-V Consortium, Foulis AK, Frisk G, Flodstrom-Tullberg M, Hober D, Hyoty H, Morgan NG (2013) Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia 57(2):392–401. doi:10.​1007/​s00125-013-3094-7
60.
Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, Fine C, Williams B, Silverman R, Sarvetnick N (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174 (3):1171–1177PubMedCrossRef
61.
Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70 (4):1032–1060PubMedCentralPubMedCrossRef
62.
Colli ML, Nogueira TC, Allagnat F, Cunha DA, Gurzov EN, Cardozo AK, Roivainen M, Op de Beeck A, Eizirik DL (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathogens 7 (9):e1002267.PubMedCentralPubMedCrossRef
63.
Cunningham L, Bowles NE, Lane RJ, Dubowitz V, Archard LC (1990) Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol 71 ( Pt 6):1399–1402PubMedCrossRef
64.
Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proceedings of the National Academy of Sciences of the United States of America 89 (1):314–318PubMedCentralPubMedCrossRef
65.
Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73 (12):10113–10121PubMedCentralPubMed
66.
Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33 (1):9–21.PubMedCrossRef
67.
Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2010) Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 53 (9):2020–2028.PubMedCrossRef
68.
Willcox A, Richardson SJ, Bone AJ, Foulis A, Morgan NG (2011) Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 54 (9):2417–2420PubMedCrossRef
69.
In’t Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, Pipeleers-Marichal M, Gorus F, Pipeleers D (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56 (9):2400–2404.PubMedCrossRef
70.
Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50 (11):2323–2331.PubMedCrossRef
71.
Krogvold L, Edwin B, Buanes T, Ludvigsson J, Korsgren O, Hyoty H, Frisk G, Hanssen KF, Dahl-Jorgensen K. (2014) Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia. doi:10.​1007/​s00125-013-3155-y.
Metadata
Title
Pancreatic Pathology in Type 1 Diabetes Mellitus
Authors
Sarah J. Richardson
Noel G. Morgan
Alan K. Foulis
Publication date
01-03-2014
Publisher
Springer US
Published in
Endocrine Pathology / Issue 1/2014
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-014-9297-8

Other articles of this Issue 1/2014

Endocrine Pathology 1/2014 Go to the issue

OriginalPaper

A Brief History of the Endocrine Pathology Society

OriginalPaper

Follicular-Patterned Afflictions of the Thyroid Gland: Reappraisal of the Most Discussed Entity in Endocrine Pathology

OriginalPaper

The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now

OriginalPaper

Medullary Thyroid Carcinoma: a 25-Year Perspective

OriginalPaper

25 Years of Neuroendocrine Neoplasms of the Gastrointestinal Tract

OriginalPaper

Understanding the Genetic Basis of Parathyroid Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits